The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

I have been writing over Chantix for just about a month now and our law firm has received dozens of inquiries about Chantix form patients claiming bizarre side effects. Just yesterday we were contacted by a couple that took the drug together and both experienced such bad side effects, including but not limited to suicidal ideation, that they had to stop taking the medication. I saw a report today from a Pennsylvania news station from a couple that claims to have had similar reactions. I have also heard several complaints recently of more persistent problems that have seemed to linger with patients even after they stop taking the medication. Most of these seem to be related to cognitive function but there have also been reports of fatigue, stomach pain, acid reflux, and depression.

Just in case you haven’t heard about Chantix yet here is brief synopsis. Chantix is a stop smoking aid that was approved for use by the FDA in May of 2006. The early results of the drug were outstanding and people have been jumping on the bandwagon ever since. Most people say that the drug has been a wonderful tool in helping them quit smoking and has been far more effective than anything else they have tried, but some seem to have unique reactions to the drug that cause serious side effects. One case that has made national news has been the death of Dallas musician, Carter Albrecht, who apparently had a psychotic episode involving intense hallucinations after he had a few drinks while on Chantix.

If you or someone you know has had a serious adverse reaction to Chantix we would like to see if we can help you. We are exploring the possible litigation against the drugs manufacturer Pfizer and would like to hear about your experience.

For more information on this subject, please refer to the section on Drugs, Medical Devices, and Implants.

Comments for this article are closed.